Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
The nonmedical use of prescription opioids is a major public health issue in the United States, both because of the overall high prevalence and because of marked increases in associated morbidity and mortality. However coinciding with efforts to reduce nonmedical prescription-opioid use and overdose are reports of increases in the rates of heroin use and deaths from heroin overdose.
A painful truth
Why should fear of drugs like heroin leave 80 per cent of the world’s population suffering unspeakable pain, asks Dr Chris Ford
Story From India
Written by Dr M.R.Rajagopal MD Chairman, Pallium India; Director, WHO Collaborating Centre for Training and Policy on Access to Pain Relief.
Emergency department-based brief interventions for individuals with substance-related problems: a review of effectiveness
Brief interventions are psychosocial techniques designed to help recipients recognise harmful patterns of substance use, and to motivate and support them to address that use. This paper considers five systematic reviews and 16 randomised controlled trials and points to the potential benefits of brief interventions, albeit with a need for more research.
Injection of new psychoactive substance snow blow associated with recently acquired HIV infections among homeless people who inject drugs in Dublin, Ireland, 2015.
In February 2015, an outbreak of recently acquired HIV infections among people who inject drugs (PWID) was identified in Dublin, following similar outbreaks in Greece and Romania in 2011. Prevention and control efforts are underway among PWID in Dublin, but may also be needed elsewhere in Europe.
The drug situation in Europe
An overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015.
WHO Recommends against International Control of Ketamine
For the fourth time since 2006, the World Health Organization (WHO) recommended that ketamine should not be placed under international control after review of the latest evidence by the WHO Expert Committee on Drug Dependence.
A shortage of oral morphine in Egypt
Egypt, with more than 88 million residents in 2015 and an estimated 5-year cancer prevalence of more than 215 000 cases in 2012, has effectively no oral morphine. The lack of effective and affordable analgesia is catastrophic for people with end-stage cancer.
A day in Mexico City
A story written by Sebastian Saville, Executive Director of IDHDP. It is a portrayal of events that took place on a day in September 2014, when though cocaine and marijuana, as well as many pharmaceutical drugs were readily available, opioids from both the illicit market and through the medical system were almost impossible to obtain.
Share this on: